补肾化瘀方联合克罗米芬治疗多囊卵巢综合症的疗效观察  被引量:29

Clinical Observation on the Treatment of Polycystic Ovary Syndrome by Bushen Huayu Prescription Combined with Clomiphene

在线阅读下载全文

作  者:伍立群[1] 李波[1] 

机构地区:[1]湖北医药学院附属随州医院,湖北随州441300

出  处:《中医药信息》2017年第2期96-99,共4页Information on Traditional Chinese Medicine

摘  要:目的:探究补肾化瘀方联合克罗米芬治疗多囊卵巢综合症的临床效果。方法:选取符合纳入标准的多囊卵巢患者72例,随机分为治疗组和对照组,每组36例,治疗组采用补肾化瘀方联合克罗米芬治疗,对照组采用克罗米芬治疗,共治疗3个月经周期。观察两组患者治疗前后的性激素水平、治疗过程中的排卵情况及不良反应发生情况。结果:治疗组的性激素LH、E2、T水平明显优于对照组,治疗组排卵率75.56%明显高于对照组的61.96%,治疗组总有效率为86.11%高于对照组的63.89%,治疗组不良反应率为5.56%低于对照组的22.22%,P均<0.05,差异均具有统计学意义。结论:补肾化瘀方联合克罗米芬治疗多囊卵巢综合征能有效的稳定性激素水平,促进排卵,提高治愈率,且不良反应小,是治疗PCOS的有效方法。Objective: To investigate the clinical effect of Bushen Huayu prescription combined with Clomiphene in the treatment of polycystic ovary syndrome. Methods: 72 cases of polycystic ovary syndrome in our hospital were randomly divided into two groups: a combined group and a control group( n = 36). The control group was treated with Clomiphene; on the basis of the therapy in the control group,the combined group was treated with Bushen Huayu prescription. After 3 menstrual cycles,the levels of sex hormones,ovulation and adverse reactions were observed before and after treatment in two groups. Results: In the combined group LH,E_2 and T of patients' hormone levels were significantly superior to those in the control group. In addition,the ovulation rate was higher than that in the control group,but the adverse reaction rate was significantly lower than that in the control group. The differences were statistically significant( P 0. 05). Conclusion: BushenHuayu prescription combined with Clomiphene can effectively stabilize the levels of sex hormones of patients with polycystic ovary syndrome. At the same time,it can promote ovulation,have a highly curative rate and reduce adverse reactions. It is an effective way to treat polycystic ovary syndrome.

关 键 词:多囊卵巢综合征 补肾化瘀方 LH E_2 T 

分 类 号:R711.75[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象